Abstract

The group of matrix metalloproteases (MMPs) is responsible for multiple processes of extracellular matrix remodeling in the healthy body but also for matrix and tissue destruction during cancer invasion and metastasis. The understanding of the contributions from each individual MMP, both in healthy and pathological events, has been complicated by the lack of specific inhibitors and the fact that some of the potent MMPs are multifunctional enzymes. These factors have also hampered the setup of therapeutic strategies targeting MMP activity. A tempting target is the membrane-associated MT1-MMP, which has well-documented importance in matrix degradation but which takes part in more than one pathway in this regard. In this report, we describe the selective targeting of a single function of this enzyme by means of a specific monoclonal antibody against MT1-MMP, raised in an MT1-MMP knock-out mouse. The antibody blocks the enzyme ability to activate proMMP-2 without interfering with the collagenolytic function or the general proteolytic activity of MT1-MMP. Using this antibody, we have shown that the MT1-MMP-catalyzed activation of proMMP-2 is involved in the outgrowth of cultured lymphatic endothelial cells in a collagen matrix in vitro, as well as in lymphatic vessel sprouting assayed ex vivo. This is the first example of the complete inactivation of a single function of a multifunctional MMP and the use of this strategy to pursue its role.

Highlights

  • Therapeutic strategies for matrix metalloproteases (MMPs) targeting have limited selectivity

  • Generation of Murine Monoclonal Antibodies against Murine and Human MT1-MMP—To obtain reagents that interfere with the individual molecular functions of MT1MMP, a panel of Monoclonal antibodies (mAbs) against it was generated

  • Whereas a low level of endogenous MT1-MMP is expressed in Chinese Hamster Ovary (CHO) cells [39] and could be detected in the untransfected cells with mAb 9E8, a strongly increased signal was noted in cells transfected with MT1-MMP cDNA

Read more

Summary

Background

Therapeutic strategies for MMP targeting have limited selectivity. Results: A novel, specific mAb against MT1-MMP selectively blocks proMMP-2 activation. We have shown that the MT1-MMP-catalyzed activation of proMMP-2 is involved in the outgrowth of cultured lymphatic endothelial cells in a collagen matrix in vitro, as well as in lymphatic vessel sprouting assayed ex vivo This is the first example of the complete inactivation of a single function of a multifunctional MMP and the use of this strategy to pursue its role. This blocking effect is complete, enabling the selective targeting of a single function of the enzyme Using this antibody, we have shown the importance of MT1-MMP mediated pro-MMP-2 activation in the sprouting of lymphatic microvessels in a collagen matrix

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call